Dye-Based Fluorescent Organic Nanoparticles, New Promising Tools for Optogenetics.
Jérémy Lesas1, Thomas C M Bienvenu2, Eleonore Kurek3
1Neurocentre Magendie, INSERM U1215, Université de Bordeaux, Bordeaux, 33000, France.
Advanced Healthcare Materials
|September 12, 2024
Summary
Dye-based fluorescent organic nanoparticles offer a bright, biocompatible platform for in vivo optogenetics. These nanoparticles successfully reduced fear responses in mice by manipulating neurons, showing potential for neurological disorder treatments.
Area of Science:
- Nanotechnology
- Biomedical Engineering
- Neuroscience
Background:
- Dye-based fluorescent organic nanoparticles are synthesized via nanoprecipitation of pure dyes.
- Their photophysical and colloidal properties depend on dye aggregation.
- Their brightness and near-infrared emission make them suitable for in vivo applications.
Purpose of the Study:
- To investigate the use of dye-based fluorescent organic nanoparticles for in vivo optogenetics.
- To demonstrate their photophysical properties, biocompatibility, and ability to activate Chrimson opsin.
- To present an example of their application in modulating fear responses.
Main Methods:
- Nanoparticle synthesis through nanoprecipitation.
- Characterization of photophysical properties and biocompatibility.
- In vivo optogenetic stimulation using fluorescence reabsorption to activate Chrimson opsin.
- Closed-loop stimulation for fear response modulation in mice.
Main Results:
- Demonstrated photophysical properties and biocompatibility of the nanoparticles.
- Confirmed activation of Chrimson opsin in vivo via fluorescence reabsorption.
- Successfully reduced fear responses in mice by selectively manipulating fear-related neurons.
- Showcased the nanoparticles' potential in a closed-loop optogenetic system.
Conclusions:
- Dye-based fluorescent organic nanoparticles are a versatile platform for in vivo optogenetics.
- These nanoparticles can effectively activate opsins and modulate neural circuits.
- This approach holds significant promise for translational neuroscience and treating neurological disorders.


